neonatology endocrinology
Neonatal Hypoglycaemia Risk Assessment
Identifies neonates at high risk for hypoglycaemia requiring glucose monitoring. Based on BAPM/NICE guidelines.
Score interpretation
Low risk
→ Encourage early feeding; no routine glucose monitoring needed if well; reassess at 2h
At-risk neonate — monitor glucose
→ Pre-feed glucose at 2, 4, 6, 12h; target glucose >=2.0 mmol/L (first 24h) then >=2.6; ensure adequate feeding
High risk or symptomatic
→ Urgent glucose check; if <2.0 mmol/L or symptomatic — IV dextrose 10% 2ml/kg bolus; NICU admission; endocrinology review if persistent
Interpretation bands for the Neonatal Hypoglycaemia. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Dextrose 10% IV · IV glucose solution (hypoglycaemia treatment)
- Glucose · Carbohydrate / hypoglycaemia treatment
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Trimetazidine · Metabolic Anti-Anginal
- Dextrose 50% (Glucose 50%) · Glucose Supplement
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.